newsfilter
← Latest News
GlobeNewswire·

ChemoCentryx to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

SAN CARLOS, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (NASDAQ:CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will participate in a fireside chat at the 11th Annual SVB Leerink Global Heal